Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma.
Tai CJ, Huang MT, Wu CH, Wang CK, Tai CJ, Chang CC, Hsieh CI, Chang YJ, Wu CJ, Kuo LJ, Wei PL, Chen RJ, Chiou HY.
Tai CJ, et al. Among authors: chang yj, chang cc.
Medicine (Baltimore). 2016 Apr;95(15):e3259. doi: 10.1097/MD.0000000000003259.
Medicine (Baltimore). 2016.
PMID: 27082562
Free PMC article.
Clinical Trial.